FDA Presentations, March 5-6, 2018 Risk Communication Advisory Committee Meeting
Opening Remarks
Malcolm J. Bertoni, M.S.
Communicating Information about Risks of Prescription Products and Vaccines Used During Pregnancy
Lynne P. Yao, M.D.
An Evolution of Labeling Information for Pregnant Women: PLLR History
and Background
Catherine Roca, M.D.
Fulfilling the Intent of PLLR: Current Approaches and Challenges
Leyla Sahin, M.D.